NRNP 6531 Week 4 Assignment: i-Human Case Study; Evaluating and Managing Cardiovascular Conditions.

NRNP 6531 Week 4 Assignment: i-Human Case Study; Evaluating and Managing Cardiovascular Conditions. Primary Diagnosis and ICD-10 Code: I20.8- Angina Pectoris E78.5- Hyperlipidemia R94.39- Abnormal result of other cardiovascular function study (Nuclear Stress test) 93000- Electrocardiogram, routine ECG with at least 12 leads: with interpretation and report 85025- CBC with differential 80061- Lipid panel 80048- BMP 83036- Hemoglobin (Hb) A1c Additional Laboratory and Diagnostic Tests: Consider a Computerized Tomography Coronary Angiography if pain continues or worsens. Consults: Angina is stable, no consult or referral is needed at this time. Therapeutic Modalities: Treatment is targeted at symptom relief and decrease disease progression to lessen event occurrence that could result in a myocardial infarction or even death (Alaeddini, 2018). Pharmacological management will include: 1. Aspirin 81 mg one tab daily (Johnson, 2018). 2. Simvastatin 40 mg daily at bedtime (Johnson, 2018). 3. Nitro stat 0.4 mg, 1 sublingual tablet dissolved under the tongue as needed for angina. May repeat every 5 minutes if needed for 15 minutes, a maximum of 3 doses (Johnson, 2018). Non-pharmacological management will include: 1. Advise patient to quit smoking to decrease the development of atherosclerosis (Alaeddini, 2018).